Literature DB >> 17658778

Allosteric inhibitors of hepatitis C polymerase: discovery of potent and orally bioavailable carbon-linked dihydropyrones.

Hui Li1, Angelica Linton, John Tatlock, Javier Gonzalez, Allen Borchardt, Mel Abreo, Tanya Jewell, Leena Patel, Matthew Drowns, Sarah Ludlum, Mike Goble, Michele Yang, Julie Blazel, Ravi Rahavendran, Heather Skor, Stephanie Shi, Cristina Lewis, Shella Fuhrman.   

Abstract

The discovery and optimization of a novel class of carbon-linked dihydropyrones as allosteric HCV NS5B polymerase inhibitors are presented. Replacement of the sulfur linker atom with carbon reduced compound acidity and greatly increased cell permeation. Further structure-activity relationship (SAR) studies led to the identification of compounds, exemplified by 23 and 24, with significantly improved antiviral activities in the cell-based replicon assay and favorable pharmacokinetic profiles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658778     DOI: 10.1021/jm0704447

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Pyridine Carboxamides: Potent Palm Site Inhibitors of HCV NS5B Polymerase.

Authors:  Cliff C Cheng; Xiaohua Huang; Gerald W Shipps; Yu-Sen Wang; Daniel F Wyss; Kyle A Soucy; Chuan-Kui Jiang; Sony Agrawal; Eric Ferrari; Zhiqing He; H-C Huang
Journal:  ACS Med Chem Lett       Date:  2010-08-17       Impact factor: 4.345

Review 2.  1,2,4-Triazolo[1,5-a]pyrimidines in drug design.

Authors:  Killian Oukoloff; Bobby Lucero; Karol R Francisco; Kurt R Brunden; Carlo Ballatore
Journal:  Eur J Med Chem       Date:  2019-01-14       Impact factor: 6.514

3.  In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Stephanie T Shi; Koleen J Herlihy; Joanne P Graham; Shella A Fuhrman; Chau Doan; Hans Parge; Michael Hickey; Jingjin Gao; Xiu Yu; Fannie Chau; Javier Gonzalez; Hui Li; Cristina Lewis; Amy K Patick; Rohit Duggal
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

4.  Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Stephanie T Shi; Koleen J Herlihy; Joanne P Graham; Jim Nonomiya; Sadayappan V Rahavendran; Heather Skor; Rebecca Irvine; Susan Binford; John Tatlock; Hui Li; Javier Gonzalez; Angelica Linton; Amy K Patick; Cristina Lewis
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

5.  Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.

Authors:  Amaravadhi Harikishore; Enlin Li; Jia Jun Lee; Nam-Joon Cho; Ho Sup Yoon
Journal:  Mol Divers       Date:  2015-04-11       Impact factor: 2.943

Review 6.  Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses.

Authors:  Rahul Kumar; Sahil Mishra; Sushil K Maurya
Journal:  RSC Med Chem       Date:  2020-12-23

7.  Thumb inhibitor binding eliminates functionally important dynamics in the hepatitis C virus RNA polymerase.

Authors:  Brittny C Davis; Ian F Thorpe
Journal:  Proteins       Date:  2012-09-15

8.  Inhibitors for the hepatitis C virus RNA polymerase explored by SAR with advanced machine learning methods.

Authors:  Iwona E Weidlich; Igor V Filippov; Jodian Brown; Neerja Kaushik-Basu; Ramalingam Krishnan; Marc C Nicklaus; Ian F Thorpe
Journal:  Bioorg Med Chem       Date:  2013-03-29       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.